The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Telmisartan and Hydrochlorothiazide
Telmisartan and Hydrochlorothiazide · TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 · Tablet · Oral · Alembic Pharmaceuticals Inc.
NDC 62332-0211-10 · 100 TABLET in 1 CARTON · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 62332-0211-30) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.6482per unit
middle half $0.2599–$1.29 · 4,856 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.6482
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
88%of plans cover it
tier 1 · prior auth 0% · step therapy 0% · qty limit 81%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for telmisartan and hydrochlorothiazide (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA203010
- TE code
- AB
- Approval date
- Feb 25, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Telmisartan and Hydrochlorothiazide (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Rottendorf Pharma GmbH | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Rottendorf Pharma GmbH | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Rottendorf Pharma GmbH | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| AvKARE | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lifestar Pharma LLC | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lifestar Pharma LLC | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lifestar Pharma LLC | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare LLC | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare LLC | TELMISARTAN 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Solco Healthcare LLC | TELMISARTAN 80 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | TELMISARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 25, 2026 |
| Aurobindo Pharma Limited | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 20, 2026 |
| Alembic Pharmaceuticals Inc. | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Inc. | TELMISARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Inc. | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | TELMISARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Alembic Pharmaceuticals Limited | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Aurobindo Pharma Limited | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | TELMISARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| AvKARE | TELMISARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | TELMISARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 80 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Telmisartan and Hydrochlorothiazide — NDC 62332-0211-10," retrieved September 3, 2026, https://drugdashboards.com/drug/62332021110.
Free to cite with attribution — see how the data is put together.